Cargando…
Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
Recombinant adenovirus vectors have been extensively used in gene therapy clinical studies. More recently, the capability of inducing potent cell-mediated and humoral immunity has made these vectors equally attractive candidates for prophylactic or therapeutic vaccine applications. Merck and Co., In...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828417/ https://www.ncbi.nlm.nih.gov/pubmed/20163742 http://dx.doi.org/10.1186/1743-422X-7-39 |